In vivo experiments, one study shows an AOM-induced colon cancer model in A/J mice was used to evaluate the effects of SB, indicating that SB significantly reduced VEGF and iNOS expression in tumor tissues and demonstrating its anti-angiogenic properties (Ravichandran et al., 2010). The gene discussed is VEGFA; the disease is malignant colon neoplasm.